Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Futura Medical Share Price
  4. Futura Medical Share Regulatory News
  5. Conference Presentation

Pin to quick picksFutura Medical Regulatory News (FUM)

Futura Medical Information

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.37    -0.03 (-7.50%)
Bid:
0.36
Ask:
0.40
Spread: 0.04 (11.111%)
Market Cap: £2.15m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Conference Presentation

4 May 2007 07:01

Futura Medical PLC04 May 2007 For immediate release 4 May 2007 Futura Medical Plc to present at Rodman and Renshaw Conference in Monaco Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovativeproducts for consumer healthcare, today announces that James Barder, its ChiefExecutive Officer, will present at the Rodman and Renshaw 4th Annual GlobalHealthcare Conference, to be held in Monte Carlo from 13 to 15 May 2007. For further information:Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk Media enquiries:Buchanan CommunicationsMark Court / Rebecca Dietrich Tel: +44 (0) 020 7466 5000 Notes to Editors Futura Medical plc Futura Medical is a pharmaceutical group that develops innovative products forconsumer healthcare. The Company is developing a portfolio of products and itsstrategy is to license their manufacture and distribution to majorpharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market ofthe London Stock Exchange. www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange
12345678910
Date   Source Headline
8th Aug 20257:00 amRNSBoard Changes, Business Update & Notice of Results
11th Jul 202511:04 amRNSShare price movement
8th Jul 20257:00 amRNSBoard Changes
20th Jun 20257:00 amRNSResult of AGM
2nd Jun 20253:15 pmRNSBlock Listing Six Monthly Return
27th May 20257:00 amRNSNotice of AGM and availability of Annual Report
24th Apr 20257:00 amRNSChange of Broker
15th Apr 20257:00 amRNSResults for the Year ended 31 December 2024
10th Apr 20251:30 pmRNSNotice of Results and Investor Presentation
31st Mar 20257:00 amRNSBoard Appointment
30th Jan 20257:00 amRNSFY24 Trading Update and FY25 Outlook
15th Jan 20257:00 amRNSPositive results from WSD4000 Home User study
13th Jan 20257:00 amRNSRemuneration of Non-Executive Directors and TVR's
20th Dec 20247:58 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSTR-1: Notification of major holdings
4th Nov 20247:00 amRNSEncouraging New Product Development Pipeline
31st Oct 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSFurther milestone payment triggered post US launch
1st Oct 20247:00 amRNSTotal Voting Rights
13th Sep 20247:00 amRNSDirectors’ / PDMR Dealing
11th Sep 20245:43 pmRNSTrinity Delta research note & consensus forecasts
10th Sep 20247:00 amRNSFutura Medical - Interim Results 2024
2nd Sep 202410:47 amRNSUpdate on US Launch
2nd Sep 20247:00 amRNSUpdate on US launch
19th Aug 20247:00 amRNSNotice of Results
1st Aug 20247:05 amRNSUpdate on US launch
1st Jul 20242:13 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSNominated Adviser and Joint Broker
20th Jun 20244:12 pmRNSResult of AGM
20th Jun 20247:00 amRNSAGM Statement
31st May 20247:00 amRNSBlock Listing Six Monthly Review
24th May 20247:00 amRNSNotice of AGM and availability of Annual Report
29th Apr 20247:00 amRNSDirectors’ / PDMR Dealing and Grant of Options
10th Apr 20247:00 amRNSResults for the Year ended 31 December 2023
25th Mar 20247:00 amRNSNotice of Results and Investor Presentation
14th Feb 20247:00 amRNSEroxon to be available on prescription
6th Feb 20247:01 amRNSTrading Update
6th Feb 20247:00 amRNSAppointment of Joint Corporate Broker
17th Jan 20247:00 amRNSDirector/PDMR Dealing
17th Jan 20247:00 amRNSRemuneration of Non-Exec Directors & Voting Rights
15th Jan 20247:00 amRNSFutura Medical extends collaboration with Cooper
9th Jan 20247:00 amRNSAppointment of Roy Davis as Non-Executive Director
30th Nov 20233:10 pmRNSTotal Voting Rights
30th Nov 20233:10 pmRNSBlock Listing Six Monthly Return
7th Nov 20237:00 amRNSFutura expands partnership with M8 Pharmaceuticals
2nd Nov 20233:34 pmRNSEroxon Awarded “New Product of the Year” by Boots
31st Oct 20237:00 amRNSBlock Listing Application and Total Voting Rights
25th Oct 20237:00 amRNSEroxon® Granted Marketing Authorisation in Mexico
19th Oct 20237:00 amRNSEroxon Launches in the United Arab Emirates
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
ELM
Elementis
LSE
1.55%
HMV
Hmv Group
LSE
0.00%
MCRO
MCRO.L
LSE
0.00%
VCT
Victrex
LSE
1.50%
FGP
Firstgroup
LSE
1.35%
Trending
GST
GSTechnologies
LSE
4.04%
LLOY
Lloyds
LSE
0.40%
GGP
Greatland Resources
LSE
-0.61%
PREM
Premier African Minerals
LSE
-2.78%
WIZZ
Wizz Air
LSE
0.51%